[ Document Reference: AETHER-PROTO ]

HPLC Purity Grading: What ≥99% Actually Means

Verification // Analytical Method · 6 min read. How HPLC/MS purity assay works, what a purity percentage does and doesn't confirm, and why the safest and purest research peptides are tested for more than purity alone.

What HPLC Purity Actually Measures

HPLC purity measures how much of a sample is the target peptide, expressed as a percentage of everything detected in the run. It does not, on its own, measure safety.

High-performance liquid chromatography separates a sample’s components by retention time: how long each one takes to travel through a column. A detector, typically UV absorbance, records a peak for each distinct component as it elutes, and the area under each peak is proportional to how much of that component is present. Purity in this context is a relative-area calculation: the target peptide’s peak area divided by the total peak area of everything detected, expressed as a percentage.

Why Mass Spectrometry Is Paired With It

HPLC alone confirms how much of the dominant peak exists. It does not confirm what that peak actually is. Pairing HPLC with mass spectrometry (HPLC‑MS) confirms the dominant peak’s molecular mass matches the expected peptide sequence, ruling out a well-separated but structurally wrong impurity, such as a truncated or deletion sequence from solid-phase synthesis, being counted as “purity” simply because it happens to elute cleanly.

Purity Is Not the Same as Safety

A high purity percentage says nothing about aggregation, heavy metals, or bacterial endotoxins. Those are three separate risk categories that a standard HPLC purity assay cannot detect, which is exactly why “purest” and “safest” are different claims that require different tests.

Aggregates. A purity assay doesn’t confirm whether the peptide is present as properly folded monomers or has partially aggregated into larger clusters during synthesis, lyophilization, or storage. It is Aether Laboratories’ standard to test every batch for aggregation separately. Most of the market doesn’t publish this data at all.

Heavy metals. Trace heavy-metal contamination is a known risk from solid-phase synthesis catalysts and reagents. HPLC does not detect it in any form; it requires a dedicated analytical method entirely separate from the purity assay. It is Aether Laboratories’ standard to test every batch for it regardless.

Endotoxins. Bacterial endotoxin contamination is a chemically unrelated risk category to peptide purity, and it’s directly relevant to any research application involving cell culture. Endotoxin testing is standard practice in biologics manufacturing but is frequently skipped in the peptide research-chemical space. It is Aether Laboratories’ standard to test for it on every batch released.

Reading a Certificate of Analysis Properly

A complete COA states the method used (HPLC‑MS, the method Aether Laboratories uses for every batch it releases), the specific purity figure obtained, the test date, and a batch identifier that traces directly back to the physical vial received. A purity number with no method disclosed, no batch identifier, and no test date attached is effectively unverifiable; there’s no way to confirm which sample it actually describes.

How to Verify a Batch’s Purity and Safety Results

Every batch in our catalog is independently verified by HPLC‑MS before it ships, with the batch identifier, test date, and assay purity figure published in the Lab Results archive alongside aggregate, heavy metal, and endotoxin results as each panel completes. Match the batch identifier printed on your vial against that archive directly. That cross-reference is the entire point of publishing it.

Purity, aggregation, heavy metals, and endotoxins are four separate tests. It is Aether Laboratories’ standard to run all four on every batch it releases.

Verification
View the Lab Results Archive →

Archive ← All Research Protocols